Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

NCT00920517 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Dengue Fever

Interventions

BIOLOGICAL: rDEN2/4delta30(ME) vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)